Stay updated on Autogene Cevumeran Combo With Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Autogene Cevumeran Combo With Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Autogene Cevumeran Combo With Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The site footer revision label changed from v3.7.2 to v3.8.0. The page continues to display a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-11-01T15:18:15.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    A notice above the error page announces NIH’s transition from “Artificial Intelligence” to “Super Intelligence” terminology and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T14:08:59.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changes from v3.7.1 to v3.7.2, while the page continues to display a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-18T14:43:38.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The site footer’s revision label changed from v3.7.0 to v3.7.1; the study page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-11T15:09:13.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error, replacing the usual study record content and navigation. This indicates access to the record is blocked, preventing viewing of the study details.
    Difference
    18%
    Check dated 2026-09-20T20:09:35.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    The study record now lists NIH grant/contract years 2018 and 2023 in the funding information, and the revision label was updated from v3.6.5 to v3.6.6.
    Difference
    0.1%
    Check dated 2026-08-30T22:25:24.000Z thumbnail image

Stay in the know with updates to Autogene Cevumeran Combo With Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Autogene Cevumeran Combo With Pembrolizumab in Melanoma Clinical Trial page.